Engitix Therapeutics
Decoding the ECM space to unlock unprecedented therapies for chronic diseases
63 employees · est. 2016 · London, United Kingdom
Immunai
Mapping the Immune System with AI to Improve Health
174 employees · est. 2019 · New York, United States
Engitix Therapeutics is the older company (2016 vs 2019).
Side-by-Side Comparison
| Metric | Engitix Therapeutics | Immunai |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2019 |
| Headquarters | ||
| Headquarters | London, United Kingdom | New York, United States |
| Employees | ||
| Employees | 63 | 174 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $59.00M | $300.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 5 |
| Services | ||
| Services | ECM Platform Development, Disease Modeling, Therapeutic Discovery, Research Collaborations | Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Firms, Medical Researchers, Healthcare Providers | biopharmaceutical companies, research institutions, pharma companies |
| Taxonomy | ||
| Taxonomy | Human Extracellular Matrix, Discovery Platform, Fibrosis Therapeutics, Solid Tumor Therapy, In Vitro Models, Drug Target Identification, Biomarker Discovery, Mechanism Of Action Study, Liver Disease Research, Regenerative Medicine, Drug Profiling, Bioartificial Liver Devices, Organ Decellularisation, Tissue Engineering, 3D Spheroids | Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology |
| Website | ||
| Website | engitix.com | immunai.com |
About Engitix Therapeutics
Engitix Therapeutics, founded in 2016 and headquartered in the United Kingdom, is at the forefront of the Biotechnology, Health Care, and Life Sciences industries. The company aims to transform therapy development for chronic diseases through its pioneering extracellular matrix (ECM)-based discovery...
About Immunai
Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...
We will tell you when either one moves
BounceWatch watches Engitix Therapeutics and Immunai for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Engitix Therapeutics and Immunai — by email.
Frequently Asked Questions
Compare Engitix Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Engitix Therapeutics on 29 Apr 2026, and Immunai on 3 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.